Suzlon Vitality shares fall 4% as Nuvama, others slash goal costs after Q2 margins disappoint. What lies forward?
Suzlon Vitality introduced its earnings within the post-market hours of Thursday, reporting a 69% year-on-year decline in consolidated web revenue to Rs 394 crore for the September quarter, whilst income elevated 26% on file wind turbine deliveries. The sharp decline in reported revenue was largely attributable to a excessive base within the year-ago quarter, when the renewable power firm recognised a one-time deferred tax asset advantage of Rs 891 crore. The shares of the corporate dropped to Rs 35.45 apiece within the early buying and selling hours of Friday.
Additionally learn | Suzlon Vitality Q2 Outcomes: Revenue plunges 69% YoY to Rs 394 crore attributable to one-time deferred tax
Excluding this one-time merchandise, Suzlon Vitality’s comparable revenue after tax elevated 1.3% from Rs 389 crore within the September quarter of FY26. Income from operations rose to Rs 4,869 crore from Rs 3,866 crore a 12 months earlier, pushed by larger wind turbine deliveries and improved mission execution.
Suzlon Vitality’s EBITDA remained practically flat at Rs 720 crore, whereas the EBITDA margin contracted to 14.8% in Q2 FY27 from 18.6% within the corresponding quarter of the earlier monetary 12 months.
Nuvama on Suzlon Vitality share value
Nuvama Institutional Equities maintained its ‘Maintain’ score on the shares of Suzlon Vitality however decreased its goal value to Rs 41 apiece from Rs 51 apiece. The most recent goal value implies greater than 11% upside potential from the inventory’s earlier closing value of Rs 36.79 apiece on NSE.
The brokerage stated Suzlon Vitality delivered sturdy execution at 710 MW, larger than the 690 MW estimate, however EBITDA margin upset at 14.8%. This was decrease than the estimate of 16.6%, resulting in a ten% miss on EBITDA and PAT. Margin weak spot displays foreign exchange or commodity headwinds and Suzlon 2.0 prices with normalised margin at 16.5-17%, it added.Regardless of excessive development on gross sales, money conversion stayed weak with receivables up Rs 5.4 billion and stock up Rs 9.5 billion, driving detrimental OCF of Rs 1.8 billion, which Nuvama listed as a key concern. The brokerage reduce FY27 and FY28 EPS estimates by 9% and seven% respectively, tweaking margin expectations to replicate EPC-led prices leap.
Additionally learn | Suzlon Vitality Q2 revenue up 1.3%, income rises 26%
Centrum Broking on Suzlon Vitality share value
Centrum Broking maintained its ‘Purchase’ score on the shares of Suzlon Vitality however decreased its goal value to Rs 68 apiece from Rs 74 apiece. The most recent goal value implies practically 85% upside potential.
“Suzlon is poised to learn from rising wind capability additions in India, backed by a sizeable order backlog, strong tender exercise and enhancing execution. Development will likely be pushed by larger turbine deliveries, commissioning ramp-up and enlargement into superior generators, DevCo, repowering and exports. Its established O&M franchise and powerful web money place present recurring earnings help and monetary flexibility, whereas margin normalisation and well timed mission execution stay key to sustaining development,” the brokerage stated.
Suzlon Vitality share value
Suzlon Vitality shares have dropped round 2% in per week and seven% in a month, with the inventory general falling practically 30% in 2026 to this point. It has general fallen greater than 37% in a single 12 months.
In the long term, Suzlon Vitality shares have gained practically 17% in three years however delivered multibagger returns of greater than 494% in 5 years. The corporate has a market capitalisation of round Rs 44,000 crore.
Additionally learn | Suzlon faces Adani, JSW problem as wind power market heats up; Q2 margins take successful
Disclaimer: This text has been written by Debaroti Adhikary, who just isn’t a SEBI-registered Analysis Analyst or an Funding Adviser. Debaroti Adhikary and his/her ‘relative(s)’ (as outlined beneath Part 2(77) of the Corporations Act, 2013) don’t maintain any monetary curiosity within the corporations talked about on this article as of the date of publication. The views/suggestions talked about on this article, wherever relevant, are these of the respective SEBI-registered Analysis Analyst/brokerage and have been reproduced/reported with due attribution. They shouldn’t be construed because the views or suggestions of The Financial Occasions Digital or the journalist. Readers are suggested to think about the unique analysis report and make their funding choices primarily based on their very own evaluation. Brokerage disclaimers right here.
